Moncitra Kid Oral Suspension is a fixed-dose combination product containing levocetirizine (2.5mg/5ml) and montelukast (4mg/5ml). This suspension is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and mild persistent asthma in pediatric patients aged 2-5 years. Levocetirizine, a histamine H1 receptor antagonist, provides fast and effective relief from symptoms such as sneezing, runny nose, and itchy, watery eyes. Montelukast, a leukotriene receptor antagonist, helps to alleviate inflammation and bronchospasm, thereby reducing the severity of respiratory symptoms. The combination of these two medications offers a comprehensive approach to managing allergic and asthmatic conditions in pediatric patients. Moncitra Kid Oral Suspension is administered once daily and is available in a child-friendly suspension formulation. As with any medication, it is essential to follow the recommended dosage and administration instructions, and to monitor patients for any signs of adverse reactions.